MDM2 and neoplasm: Previous studies identified SP-141 as a potent MDM2 inhibitor (Ki = 28 nM) based on SAR studies and its anti-tumor activity in multiple human tumor xenografts, including MCF-7 and HepG2 [24,25,28].